Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy
Authors
Keywords
-
Journal
Frontiers in Aging Neuroscience
Volume 6, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-07-29
DOI
10.3389/fnagi.2014.00171
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systemic Inflammation and the Risk of Alzheimer's Disease and Dementia: A Prospective Population-Based Study
- (2017) Johan Sundelöf et al. JOURNAL OF ALZHEIMERS DISEASE
- Neuroinflammation in Alzheimer's Disease: Are NSAIDs and Selective COX-2 Inhibitors the Next Line of Therapy?
- (2017) Catherine H. Trepanier et al. JOURNAL OF ALZHEIMERS DISEASE
- The Vascular Component of Alzheimer’s Disease
- (2014) Dafin Muresanu et al. CURRENT NEUROVASCULAR RESEARCH
- Capillary pericytes regulate cerebral blood flow in health and disease
- (2014) Catherine N. Hall et al. NATURE
- Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice
- (2014) E. A. Winkler et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Blood-CNS Barrier Impairment in ALS patients versus an animal model
- (2014) Svitlana Garbuzova-Davis et al. Frontiers in Cellular Neuroscience
- Agitation and aggression in people with Alzheimerʼs disease
- (2013) Clive Ballard et al. CURRENT OPINION IN PSYCHIATRY
- Differential Relationships of Reactive Astrocytes and Microglia to Fibrillar Amyloid Deposits in Alzheimer Disease
- (2013) Alberto Serrano-Pozo et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Sustained Interleukin-1 Overexpression Exacerbates Tau Pathology Despite Reduced Amyloid Burden in an Alzheimer's Mouse Model
- (2013) S. Ghosh et al. JOURNAL OF NEUROSCIENCE
- CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology
- (2013) Elizabeth M Bradshaw et al. NATURE NEUROSCIENCE
- Increased blood–brain barrier vulnerability to systemic inflammation in an Alzheimer disease mouse model
- (2013) Shuko Takeda et al. NEUROBIOLOGY OF AGING
- The Pathobiology of Vascular Dementia
- (2013) Costantino Iadecola NEURON
- Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta
- (2013) Ana Griciuc et al. NEURON
- Roles of vascular and metabolic components in cognitive dysfunction of Alzheimer disease: short- and long-term modification by non-genetic risk factors
- (2013) Naoyuki Sato et al. Frontiers in Aging Neuroscience
- Oligodendrocytes and the early multiple sclerosis lesion
- (2012) John W. Prineas et al. ANNALS OF NEUROLOGY
- Blood-Brain Barrier P-Glycoprotein Function in Neurodegenerative Disease
- (2012) A.L. Bartels CURRENT PHARMACEUTICAL DESIGN
- Treatment of Behavioral and Psychological Symptoms of Alzheimer’s Disease
- (2012) Anne Corbett et al. Current Treatment Options in Neurology
- The Role of Peripheral Inflammatory Markers in Dementia and Alzheimer's Disease: A Meta-Analysis
- (2012) A. Koyama et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Apolipoprotein E controls cerebrovascular integrity via cyclophilin A
- (2012) Robert D. Bell et al. NATURE
- Progressive multiple sclerosis: pathology and pathogenesis
- (2012) Hans Lassmann et al. Nature Reviews Neurology
- Neuroinflammatory Imaging Biomarkers: Relevance to Multiple Sclerosis and its Therapy
- (2012) Thomas Tourdias et al. Neurotherapeutics
- Systemic inflammation and Alzheimer's disease
- (2011) Clive Holmes et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- The role of neuroinflammation on the pathogenesis of Parkinson's disease
- (2011) Young-Cheul Chung et al. BMB Reports
- ‘Clinical trials in Alzheimer’s disease’: immunotherapy approaches
- (2011) Julien Delrieu et al. JOURNAL OF NEUROCHEMISTRY
- Engaging neuroscience to advance translational research in brain barrier biology
- (2011) Edward A. Neuwelt et al. NATURE REVIEWS NEUROSCIENCE
- The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia
- (2010) Costantino Iadecola ACTA NEUROPATHOLOGICA
- Inflammation and Alzheimer’s disease
- (2010) Young-Jung Lee et al. ARCHIVES OF PHARMACAL RESEARCH
- Magnetic Resonance Imaging Detection and Time Course of Cerebral Microhemorrhages during Passive Immunotherapy in Living Amyloid Precursor Protein Transgenic Mice
- (2010) F. Luo et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Systemic infection and delirium: when cytokines and acetylcholine collide
- (2010) Willem A van Gool et al. LANCET
- Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and A deposition in an Alzheimer mouse model with diabetes
- (2010) S. Takeda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease
- (2009) Robert D. Bell et al. ACTA NEUROPATHOLOGICA
- APOEpredicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging
- (2009) John C. Morris et al. ANNALS OF NEUROLOGY
- Alzheimer Disease–Associated Peptide, Amyloid β40, Inhibits Vascular Regeneration With Induction of Endothelial Autophagy
- (2009) Shin-ichiro Hayashi et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Massive gliosis induced by interleukin-6 suppresses Aβ deposition in vivo: evidence against inflammation as a driving force for amyloid deposition
- (2009) Paramita Chakrabarty et al. FASEB JOURNAL
- Angiotensin Receptor Blocker Prevented β-Amyloid-Induced Cognitive Impairment Associated With Recovery of Neurovascular Coupling
- (2009) Shuko Takeda et al. HYPERTENSION
- Age and Neuroinflammation: A Lifetime of Psychoneuroimmune Consequences
- (2009) Jonathan P. Godbout et al. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy
- (2009) Guojun Bu NATURE REVIEWS NEUROSCIENCE
- Fibrillar amyloid- burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease
- (2009) E. M. Reiman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Disease-modifying therapies in Alzheimer’s disease
- (2008) Stephen Salloway et al. Alzheimers & Dementia
- Long-Term Cognitive Outcome of Delirium in Elderly Hip Surgery Patients
- (2008) Martin G. Kat et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Imaging of Peripheral Benzodiazepine Receptor Expression as Biomarkers of Detrimental versus Beneficial Glial Responses in Mouse Models of Alzheimer's and Other CNS Pathologies
- (2008) B. Ji et al. JOURNAL OF NEUROSCIENCE
- The renin-angiotensin system, hypertension and cognitive dysfunction in alzheimer's disease: new therapeutic potential
- (2007) Shuko Takeda Frontiers in Bioscience-Landmark
- β-Amyloid deposition in brain is enhanced in mouse models of arterial hypertension
- (2007) Maria Teresa Gentile et al. NEUROBIOLOGY OF AGING
- Screening of innate immune receptors in neurodegenerative diseases: A similar pattern
- (2007) Maryse Letiembre et al. NEUROBIOLOGY OF AGING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation